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oAbstract
Background: Patients with acute respiratory distress syndrome receiving mechanical
ventilation show inhomogeneous lung aeration. Atelectasis during uneven
mechanical ventilation leads to alveolar hypoxia and could therefore result in lung
inflammation and injury. We aimed to elucidate whether and how atelectasis causes
alveolar hypoxia-induced inflammation during uneven mechanical ventilation in an
open-chest differential-ventilation rat model.
Methods: We first investigated inflammatory and histological changes in the bilateral
lungs of unilaterally ventilated rats, in which the right lung was atelectatic and the
left lung was ventilated with high tidal volume (HTV). In the next series, we
investigated the effects of normal tidal volume (NTV) ventilation of the right lungs
with 60 % O2 or 100 % N2 during HTV ventilation of the left lungs. Then,
proinflammatory cytokine secretions were quantified from murine lung epithelial
(MLE15) and murine alveolar macrophage (MH-S) cells cultured under a hypoxic
condition (5 % O2) mimicking atelectasis. Further, activities of nuclear factor (NF)-κB
and hypoxia-inducible factor (HIF)-1 were assessed in the nonventilated atelectatic
lung and MLE15 cells cultured under the hypoxic condition. Finally, effects of NF-κB
inhibition and HIF-1α knockdown on the cytokine secretions from MLE15 cells
cultured under the hypoxic condition were assessed.
Results: The nonventilated atelectatic lungs showed inflammatory responses and
minimal histological changes comparable to those of the HTV-ventilated lungs. NTV
ventilation with 60 % O2 attenuated the increase in chemokine (C-X-C motif) ligand
(CXCL)-1 secretion and neutrophil accumulation observed in the atelectatic lungs,
but that with 100 % N2 did not. MLE15 cells cultured with tumor necrosis factor
(TNF)-α under the hypoxic condition showed increased CXCL-1 secretion. NF-κB and
HIF-1α were activated in the nonventilated atelectatic lungs and MLE15 cells cultured
under the hypoxic condition. NF-κB inhibition abolished the hypoxia-induced increase
in CXCL-1 secretion from MLE15 cells, while HIF-1α knockdown augmented it.
Conclusions: Atelectasis causes alveolar hypoxia-induced inflammatory responses
including NF-κB-dependent CXCL-1 secretion from lung epithelial cells. HIF-1 activation
in lung epithelial cells is an anti-inflammatory response to alveolar hypoxia in atelectatic
lungs.
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Patients with acute respiratory distress syndrome receiving mechanical ventilation show
inhomogeneous lung aeration. Dependent atelectatic regions are poorly aerated while
nondependent aerated regions are ventilated with relatively high tidal volume (HTV).
HTV ventilation of nondependent regions causes overinflation and barotrauma [1].
Moreover, peri-atelectatic regions augment mechanical stress [2], and repetitive shear
stress caused by alveolar collapse and re-opening deteriorates lung injury [3–5]. Not-
ably, alveolar O2 tension rapidly decreases to a mixed venous level in atelectatic lungs
[6], leading to alveolar hypoxia, a potent inducer of lung inflammation [7]. Therefore,
atelectasis could deteriorate ventilator-associated lung injury (VALI) by alveolar
hypoxia-induced inflammation during uneven mechanical ventilation. However, the
role of atelectasis in VALI is not fully elucidated.
Nuclear factor (NF)-κB and hypoxia-inducible factor (HIF)-1 are transcription factors
that regulate hypoxic inflammation [8, 9]. NF-κB has a central role in the transcription of
proinflammatory mediators, responsible for inflammatory diseases including lung injury
[10]. It is inactive when bound to inhibitors of κB (IκB) in the cytoplasm, but IκB phos-
phorylation by IκB kinase leads to liberation and nuclear translocation of NF-κB. Hypoxia
activates IκB kinase through inhibition of prolyl hydroxylase (PHD)-1 and enhances nu-
clear translocation of NF-κB [11]. HIF-1 is a heterodimer consisting of HIF-1α and HIF-1β.
In normoxic conditions, specific proline residues of HIF-1α are hydroxylated by PHD and
HIF-1α is ubiquitinated and degraded, while HIF-1β is constitutively present in excess.
Hypoxia inhibits HIF-1α hydroxylation by PHD and activates HIF-1. HIF-1 is a key regula-
tor of hypoxic responses and modulates transcription of numerous genes associated with
adaptation to hypoxia [12]. It also plays essential roles in regulating inflammation [13–17].
To elucidate whether and how atelectasis causes alveolar hypoxia-induced inflammation,
we used an open-chest differential-ventilation rat model. First, we investigated inflamma-
tion and histological changes in the bilateral lungs of unilaterally ventilated rats, in which
the right lung was atelectatic and the left lung was ventilated with HTV. Next, we investi-
gated the effects of normal tidal volume (NTV) ventilation of the right lungs with 60 % O2
(nonhypoxic condition) or 0 % O2 (hypoxic condition) during HTV ventilation of the left
lungs. Then, we studied the responses of two potent sources of inflammatory mediators in
the lungs: lung epithelial and alveolar macrophage cells, under a hypoxic condition
mimicking atelectasis. To clarify the mechanisms of lung injury, we investigated the roles
of NF-κB and HIF-1 in hypoxia-induced inflammatory responses in lung epithelial cells.Methods
Animals
The Animal Research Committee of Yokohama City University approved the animal
experiments. Specific pathogen-free male Sprague–Dawley rats aged 9–10 weeks and
weighing 300–400 g were used. The animals were housed under a 12-h light/dark cycle
with unrestricted access to food and water.Ventilation protocols
The animals were anesthetized with an intraperitoneal injection of sodium pentobar-
bital (16 mg), and 0.5 % bupivacaine was injected into the surgical site for analgesia.
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containing 0.5 % sodium pentobarbital was continuously injected (4 mL/kg/h) via the
right femoral vein. Body temperature was maintained between 36.5 and 38.0 °C by pla-
cing the rats on a warming device. After tracheotomy, a 16-gauge plastic cannula proc-
essed with a broadened tip was inserted into the trachea. After administration of 1-mg
pancuronium bromide and initiation of mechanical ventilation, bilateral thoracotomy
was performed to visualize the lungs.
Rats were assigned to one of two ventilation protocols (eight animals per protocol): bi-
lateral lung ventilation (BLV) and unilateral lung ventilation (ULV). BLV was initiated and
maintained by using a constant-volume pump (SN-480-7, Shinano Seisakusho, Tokyo,
Japan) with the following parameters: tidal volume, 8 mL/kg; frequency, 80/min; and posi-
tive end-expiratory pressure (PEEP), 4 cmH2O. For ULV, the 16-gauge tracheal cannula
was advanced into the left main bronchus and the left lung was ventilated with the same
parameter setting for BLV: tidal volume, 8 mL/kg; frequency, 80/min; and PEEP, 4
cmH2O. Immediately thereafter, a 20-gauge plastic cannula was inserted into the trachea
through the tracheotomy site in the ULV group. The gap between the cannula and the tra-
chea was sealed with instant adhesive (Aron Alpha, Toagosei, Tokyo, Japan) to prevent air
leakage. The 20-gauge tracheal cannula was open to atmospheric pressure, and the
right lung was collapsed. The inspired O2 fraction of the ventilated lungs was 1.0 dur-
ing the first hour to prevent severe hypoxemia before establishment of hypoxic pul-
monary vasoconstriction and then reduced to 0.6. Before and every 1 h after the
ventilation protocols were applied, the ventilated lungs were inflated at 30 cmH2O
for 5 s to prevent atelectasis.
In the next series of experiments, we evaluated the effects of NTV ventilation of right
lungs with different gaseous mixtures during HTV ventilation of the left lungs. Rats were
assigned to one of three ventilation protocols: ULV, NTV60 %, and NTV0 %. In all the
groups, the left lung was ventilated through the 16-gauge cannula in the left main bron-
chus with the following parameters: tidal volume, 8 mL/kg; frequency, 80/min; and PEEP,
4 cmH2O. The ventilation protocol of the ULV group was the same to that of the first
series experiment. For NTV ventilation of the right lung, the 20-gauge tracheal cannula
was connected to another constant-volume pump and the right lung was ventilated with
the following parameters: tidal volume, 4 mL/kg; frequency, 80/min; and PEEP, 4 cmH2O.
The inspired O2 fraction of the right NTV lung was either 60 or 0 % O2 (100 % N2).
Mean arterial pressure (MAP) and peak airway pressure (Paw) were recorded, and ar-
terial blood was collected for blood gas analysis before and every 2 h after the ventila-
tion protocols, and the volume of blood obtained was replaced with the same volume
of 6 % hydroxyethyl starch solution (Hespander, Fresenius Kabi Japan, Tokyo, Japan).
After 8 h of ventilation, the rats were deeply anesthetized and euthanized by exsanguin-
ation from the right carotid artery. Their pulmonary vessels were flushed with 50 mL
of ice-cold normal saline containing 0.3-mM ethylenediaminetetraacetic acid by gravity
infusion at 30 cmH2O via the right ventricle, and the lungs were excised.Cell culture
Murine lung epithelial (MLE15) and murine alveolar macrophage (MH-S) cells were
plated on 12-well plates (2.5 × 105 cells per well ) and cultured in RPMI-1640 (Nacalai
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spectively, for 24 h. The cells were then FBS-starved for 12 h. Subsequently, the culture
medium was exchanged to FBS-free medium with or without 500 pg/mL tumor necro-
sis factor (TNF)-α (PeproTech, Rocky Hill, NJ) to simulate a sterile inflammatory envir-
onment, and the cells were cultured in either 21 % (nonhypoxic condition) or 5 %
(hypoxic condition) O2 by using CulturePal5 (Mitsubishi Gas Chemical Company,
Tokyo, Japan) for 24 h. Conditioned medium was collected and centrifuged at 3000g
for 10 min at 4 °C. The supernatants were aliquoted and stored at −80 °C until use. Fi-
nally, the cells were lysed for either protein or RNA extraction.Histopathology
Lung tissues were fixed in paraformaldehyde and embedded in paraffin as described
previously [18], and their sections were stained with hematoxylin and eosin. A path-
ologist blinded to the allocation of the ventilation protocols assessed and scored the
degree of lung histological changes. Perivascular and peribronchial edema, infiltra-
tion of leukocytes into the alveolar spaces, and leukocyte stasis and attachment to
the intima of the vascular walls were independently scored as 0, none; 1, mild-to-
moderate; or 2, severe. The sum of each score (range, 0 to 6) was defined as the
histological score.ELISA
Frozen lung blocks were homogenized in 10 volumes of phosphate-buffered saline
containing 0.5 % Triton-X and 1.0 % proteinase inhibitor cocktail (25954–21, Nacalai
Tesque) on ice and centrifuged at 10,000g for 10 min at 4 °C. The supernatants were
aliquoted and stored at −80 °C until use. The concentrations of TNF-α (DY510,
R&D Systems, Minneapolis, MN), chemokine (C-X-C motif ) ligand (CXCL)-1
(DY515, R&D Systems), chemokine (C-C motif ) ligand (CCL)-2 (900-M59, Pepro-
Tech), and myeloperoxidase (MPO) (DY3667, R&D Systems) were determined by
enzyme-linked immunosorbent assay (ELISA). The values were normalized to the
total protein concentration measured by a BCA protein assay kit (Thermo Fisher
Scientific, Yokohama, Japan).
CXCL-1 (DY453, R&D Systems), CCL-2 (900-K126, PeproTech), and TNF-α (DY410,
R&D Systems) in cell-culture supernatants were quantified by ELISA according to the man-
ufacturers’ instructions. Each cytokine concentration was normalized to the relative cell
density determined by naphthol blue-black staining.
For HIF-1, lung tissues were homogenized in RIPA buffer (ab156034, Abcam, Cambridge,
UK) and sonicated on ice. Cultured cells were washed with ice-cold PBS twice and lysed
with ice-cold RIPA buffer for 1 h on ice. Lung tissue homogenates and cell lysates were cen-
trifuged at 10,000g for 10 min at 4 °C, and HIF-1α in the supernatants was quantified by
ELISA (DY-1935, R&D Systems).NF-κB p65 binding activity assay
The NF-κB p65 binding activities of whole cell lysates of lung tissues were quantified
by ELISA (TransAM NFκB p65, Active Motif, Carlsbad, CA). Those of nuclear proteins
extracted from cultured cells by using the NE-PER Nuclear and Cytoplasmic Extraction
Tojo et al. Intensive Care Medicine Experimental  (2015) 3:18 Page 5 of 17Reagent Kit (Thermo Fisher Scientific) were also quantified by ELISA (10007889,
Cayman Chemical, Ann Arbor, MI). The activities were normalized to the total protein
concentration.Reverse transcription-qPCR
RNA was extracted from frozen lung blocks by using Sepasol-RNA Super G (Nacalai
Tesque) and from cultured cells by using RNA extraction columns (NucleoSpin RNA
II, Takara Bio, Shiga, Japan). Reverse transcription-PCR was performed to obtain
cDNA. Then, reverse transcription-quantitative polymerase chain reaction (qPCR)
was performed by using SYBR Premix ExTaq (Takara Bio) with specific primers (Life
Technologies Japan, Tokyo, Japan) (Table 1) under the following conditions: 30 s at
95 °C and 40 cycles for 5 s at 95 °C and 30 s at 60 °C (iCycler, Bio-Rad Laboratories,
Hercules, CA). Changes in HIF1A, vascular endothelial growth factor A (VEGFA),
and glucose transporter-1 (GLUT1) mRNA expressions relative to β-actin (ACTB)
mRNA expression were calculated.NF-κB inhibition and HIF-1α knockdown
To inhibit NF-κB activity, 10 nM of Bay 11–7082 (Wako Pure Chemical Industries,
Osaka, Japan), a selective IκB kinase inhibitor, was administered 1 h before the hyp-
oxic challenge in MLE15 cells. For HIF-1α knockdown, MLE15 cells were transfected
with HIF-1α small interfering RNA (siRNA) (siGENOME Mouse Hif1a siRNA
SMARTpool, Thermo Fisher Scientific) by using Lipofectamine RNAiMAX (Life
Technologies Japan). Control cells were transfected with nontarget siRNA (siGEN-
OME Non-Targeting siRNA Pool #1, Thermo Fisher Scientific). Before the experi-
ments, the cells were incubated in a transfection mixture for 24 h followed by
incubation in FBS-free medium for 12 h.Statistical analysis
Data are presented as means ± SEM or medians (interquartile ranges). Two-way
repeated-measures analysis of variance (ANOVA) followed by Student’s t test withTable 1 Primers for qPCR
Gene Primer Sequence
Mouse HIF1A Forward 5′-ATCAAGTCAGCAACGTGGAA-3′
Reverse 5′-AATGGGTTCACAAATCAGCAC-3′
Rat and mouse VEGFA Forward 5′-TGCTGTACCTCCACCATGC-3′
Reverse 5′-GATGTCCACCAGGGTCTCAA-3′
Rat GLUT1 Forward 5′-CCCTGCAGTTCGGCTATAA-3′
Reverse 5′-AGTGTGGTGAGTGTGGTGGA-3′
Mouse GLUT1 Forward 5′-TTATTGCCCAGGTGTTTGG-3′
Reverse 5′-GTTACGATTGATGAGCAGGAAG-3′
Rat ACTB Forward 5′-TGACGTTGACATCCGTAAAGAC-3′
Reverse 5′-AGAGCCACCAATCCACACA-3′
Mouse ACTB Forward 5′-TGACAGGATGCAGAAGGAGA-3′
Reverse 5′-GCTGGAAGGTGGACAGTGAG-3′
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Histological scores were analyzed with Kruskal–Wallis test followed by Dunn’s
multiple comparison test. One-way ANOVA followed by Dunnett’s test was per-
formed to compare the ULV, NTV60 %, and NTV0 % groups. Student’s t test was
performed to compare cell-culture findings. Two-way ANOVA followed by Stu-
dent’s t test with Bonferroni correction was performed for multiple comparisons of
the cell-culture experiments. Cytokine concentrations were analyzed after perform-
ing log transformations to adjust the standard deviations. GraphPad Prism 6
(GraphPad Software, La Jolla, CA) was used for all statistical analyses. Statistical sig-
nificance was set at p < 0.05.Results
Mean arterial pressure, peak airway pressure, and arterial blood gas analysis
MAP was not significantly different between the groups until 360 min; however, it was
lower in the ULV group than in the BLV group at 480 min (70 ± 18 vs. 98 ± 20 mmHg,
p = 0.0444) (Fig. 1a). The peak Paw was higher in the ULV group than that in the BLV
group (Fig. 1b). Arterial partial pressure of O2 (PaO2) was significantly higher in the
BLV group than that in the ULV group at all the time points after the initiation of ven-
tilation protocols (Fig. 1c). Arterial partial pressure of CO2 (PaCO2) was not signifi-
cantly different between these groups (Fig. 1d).Fig. 1 Mean arterial pressure, peak airway pressure, and arterial blood gas analysis. a Mean arterial pressure,
b peak airway pressure, c PaO2, and d PaCO2. *p < 0.05 compared with the BLV group (n = 8 rats per
group). PaO2 arterial partial pressure of oxygen, PaCO2 arterial partial pressure of carbon dioxide, BLV
bilateral lung ventilation, ULV unilateral lung ventilation
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TNF-α, CXCL-1, CCL-2, and MPO were detected in lung homogenates of the BLV group
(Fig. 2). ULV significantly increased the levels of TNF-α (F(1, 14) = 72.87, p < 0.0001)
(Fig. 2a) and CXCL-1 (F(1, 14) = 28.53, p < 0.0001) (Fig. 2b) in bilateral lungs. The degrees
of increases in TNF-α and CXCL-1 were similar in the bilateral lungs of the ULV
group (effect of interaction F(1, 14) = 0.9889, p = 0.3669, and F(1, 14) = 0.8173, p =
0.3813, respectively). No significant change in the CCL-2 level was observed between
the two groups (Fig. 2c). The CCL-2 level was significantly increased in the left HTV-
ventilated lungs compared to the right atelectatic lung in the ULV group (p = 0.0365).
Consistent with the change in the level of CXCL-1: a potent neutrophil chemoattract-
ant, the concentration of MPO: an indicator of neutrophil accumulation, was signifi-
cantly higher in the bilateral lungs of the ULV group compared to that in the BLV
group (p < 0.0001) (Fig. 2d). Moreover, the concentration of MPO was significantly
higher in the right atelectatic lung than that in the left HTV-ventilated lung in the
ULV group (p = 0.0022).Histological examination
In the BLV group, almost-normal structures were noted in both lungs (Fig. 3a, b).
Perivascular and peribronchial edema, leukocytic infiltration of alveolar spaces, and
leukocyte stasis and attachment to the tunica intima of the vascular walls were mod-
estly observed in the ULV group, especially in the right atelectatic lung (Fig. 3c, d, e).
However, the histological changes were relatively minimal and other indicativeFig. 2 Concentrations of proinflammatory cytokines and MPO in the right (atelectatic) and the left (ventilated
with high tidal volume) lung homogenates. a TNF-α, b CXCL-1, c CCL-2, and d MPO concentrations were
measured by ELISA and normalized to the total protein concentration. *p < 0.05 compared with the BLV group,
†p < 0.05 compared with the right lungs (n= 8 rats per group). TNF-α tumor necrosis factor α, CXCL-1 chemokine
(C-X-C motif) ligand 1, CCL-2 chemokine (C-C motif) ligand 2, MPO myeloperoxidase
Fig. 3 Histological assessment of lung sections after 8 h of ventilation. a–e Representative images of lung sections
stained with hematoxylin and eosin. a Right and b left lung sections from the BLV group and c right (atelectatic)
and d left (ventilated with high tidal volume) lung sections from the ULV group. e High-magnification images of
perivascular edema from right lung sections of the ULV group. Arrows indicate neutrophils adhering to tunica
intima and infiltrating to the perivascular edema. Scale bar = 200 μm. f Histological scores. BLV bilateral lung
ventilation, ULV unilateral lung ventilation
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aceous debris in the alveolar space, or thickening of the alveolar wall [19], were not
observed. The histological scores were not significantly different between the BLV
and ULV groups (Fig. 3f ).NF-κB and HIF-1 activities
NF-κB p65 binding activities are increased in the atelectatic lungs of the ULV group
compared with the BLV group (2.01 ± 0.30 vs. 1.00 ± 0.09, p = 0.0070) (Fig. 4a). HIF-
1α concentrations (3658 ± 311.6 vs. 1249 ± 186.7 pg/g protein, p < 0.0001) (Fig. 4b)
and mRNA levels of HIF-1 downstream genes VEGFA (2.630 ± 0.3778 vs. 1.000 ±
Fig. 4 Activities of NF-κB and HIF-1 in right lungs a NF-κB p65 binding activities and b HIF-1α protein
concentrations in right lung homogenates quantified by ELISA. c VEGFA and d GLUT1 mRNA levels in
right lung homogenates measured by qPCR. *p < 0.05 compared with the BLV group (n = 8 samples per
group). NF-κB nuclear factor-κB, HIF-1 hypoxia-inducible factor 1, VEGFA vascular endothelial growth factor
A, GLUT1 glucose transporter-1, BLV bilateral lung ventilation, ULV unilateral lung ventilation
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(Fig. 4d) were also significantly increased in these lungs of the ULV group.Effects of NTV ventilation with 60 % O2 or 100 % N2 on lung inflammation
NTV ventilation of the right lungs with 60 % O2 or 100 % N2 did not significantly alter the
TNF-α level compared to the ULV group (Fig. 5a). NTV ventilation with 60 % O2 signifi-
cantly attenuated the increase in CXCL-1 (562.5 ± 156.7 vs. 225.1 ± 36.31 pg/mg protein,
p = 0.0243) and MPO (115.6 ± 7.212 vs. 87.73 ± 6.375 ng/mg protein, p = 0.0148) levels ob-
served in the ULV group (Fig. 5b, c). No significant changes in CXCL-1 (562.5 ± 156.7 vs.
347.4 ± 44.36 pg/mg protein, p = 0.3644) and MPO (115.6 ± 7.212 vs. 109.9 ± 4.834 ng/mg
protein, p = 0.7445) concentrations were observed between the atelectatic lungs of the
ULV group and the lungs ventilated with 100 % N2. NF-κB p65 binding activity and the
concentration of HIF-α were decreased in the NTV60 % group compared to the ULV
group (Fig. 5d, e). The concentration of HIF-1α was significantly increased in the NTV0 %
group compared to that in the ULV group.Cytokine secretion in vitro
Next, we investigated the effects of hypoxia on cytokine secretion from murine lung epi-
thelial (MLE15) and alveolar macrophage (MH-S) cells. We treated these cells with TNF-α
because TNF-α is known as an essential mediator for the pathogenesis of VALI [20, 21]
and the concentration of TNF-α was not affected by NTV ventilation with 60 % O2 in our
in vivo experiment. MLE15 cells cultured in 5 % O2 secreted a significantly higher concen-
tration of CXCL-1 than those cultured in 21 % O2 after treatment with TNF-α (5568 ±
Fig. 5 Concentrations of proinflammatory cytokines and MPO and activity of NF-κB and HIF-1α in right lung
homogenates. a TNF-α, b CXCL-1, and c MPO concentrations and d NF-κB p65 binding activities and e HIF-1α
concentrations in right lung homogenates were measured by ELISA and normalized to the total protein
concentration. *p < 0.05 compared with the ULV group (n = 5 rats per group). TNF-α tumor necrosis factor
α, CXCL-1 chemokine (C-X-C motif) ligand 1, MPO myeloperoxidase, NF-κB nuclear factor-κB, HIF-1
hypoxia-inducible factor 1, ULV unilateral lung ventilation, NTV normal tidal volume
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MLE15 cells not treated with TNF-α. Further, the concentration of CCL-2 secreted from
MH-S cells was not significantly different in any culture condition (Fig. 6b).
TNF-α was not detected in the supernatants of MLE15 or MH-S cells, and CXCL-1
was not detected in the supernatants of MH-S cells. CCL-2 was detected in MLE15 cell
supernatants only after TNF-α treatment and at a much lower level than that observed
in the MH-S cell supernatants (data not shown).
Exposure to 5 % O2 significantly increased the binding activity of NF-κB p65 in
MLE15 cells cultured with TNF-α (1.49 ± 0.14 in 5 % O2 vs. 1.00 ± 0.14 in 21 % O2, p =
0.0367) (Fig. 6c). HIF-1α concentrations (97.1 ± 4.5 pg/mg protein in 5 % O2 vs. 44.5 ±
0.31 pg/mg protein in 21 % O2, p < 0.0001) (Fig. 6d) and VEGFA (1.88 ± 0.22 in 5 % O2
vs. 1.00 ± 0.11 in 21 % O2, p = 0.0071) (Fig. 6e) and GLUT1 (2.83 ± 0.66 in 5 % O2 vs.
1.00 ± 0.11 in 21 % O2, p = 0.0252) (Fig. 6f ) mRNA expressions also increased in
MLE15 cells cultured with TNF-α under the hypoxic condition.
Fig. 6 Effect of hypoxia on cytokine secretion from MLE15 and MH-S cells and activities of NF-κB and HIF-1α
in MLE15 cells. a, b Cells were cultured in 21 % O2 (white bar) or 5 % O2 (black bar) with or without TNF-α
(500 pg/mL). a CXCL-1 secreted from MLE15 cells and b CCL-2 secreted from MH-S cells. (n = 6 samples per
group). c–f MLE15 cells were cultured in 21 % O2 (white bar) or 5 % O2 (black bar) with TNF-α (500 pg/mL).
c NF-κB p65 binding activities (n = 5 samples per group) and d HIF-1α concentrations in MLE15 cells (n = 4
samples per group). e VEGFA and f GLUT1 mRNA levels in MLE15 cells (n = 5 samples per group). *p < 0.05
compared with the 21 % O2 group, †p < 0.05 compared with the group without TNF-α. TNF-α tumor necrosis
factor α, CXCL-1 chemokine (C-X-C motif) ligand 1, CCL-2 chemokine (C-C motif) ligand 2, NF-κB nuclear
factor-κB, HIF-1 hypoxia-inducible factor 1, VEGFA vascular endothelial growth factor A, GLUT1
glucose transporter-1
Tojo et al. Intensive Care Medicine Experimental  (2015) 3:18 Page 11 of 17Roles of NF-κB and HIF-1 in hypoxia-induced inflammatory responses
NF-κB inhibition by Bay 11–7082 abolished the hypoxia-induced upregulation of CXCL-1
in MLE15 cells cultured with TNF-α (two-way ANOVA: effect of oxygen concentration
F(1, 20) = 10.53, p = 0.0041; effect of NF-κB inhibition F(1, 20) = 40.73, p < 0.0001; inter-
action F(1, 20) = 7.122, p = 0.0148; post hoc analysis: 21 vs. 5 % O2 in vehicle group, p =
0.0018; 21 vs.5 % O2 in Bay 11–7082 group, p > 0.9999) (Fig. 7a). HIF-1α knockdown
effectively decreased HIF1A,VEGFA, and GLUT1 mRNA levels (Fig. 7b) and the HIF-1α
protein concentration (Fig. 7c). However, it increased CXCL-1 secretion from MLE15 cells
cultured with TNF-α (two-way ANOVA: effect of oxygen concentration F(1, 20) = 9.401,
p = 0.0061; effect of HIF-1α knockdown F(1, 20) = 21.38, p = 0.0002; interaction F(1, 20) =
3.665, p = 0.0700) (Fig. 7d).
Fig. 7 Effects of NF-κB inhibition and HIF-1α knockdown on cytokine secretion from MLE15 cells. Cells were
cultured in 21 % O2 (white bar) or 5 % O2 (black bar) with TNF-α (500 pg/mL). a CXCL-1 secretion from MLE15
cells cultured with 500 pg/mL TNF-α after treatment with Bay 11–7082 or vehicle. *p < 0.05 compared with the
21 % O2 group (n = 6 samples per group). b HIF1A, VEGFA, and GLUT1 mRNA levels and c HIF-1α protein
concentrations in MLE15 cells transfected with HIF-1α or nontarget siRNA. *p < 0.05 compared with the
nontarget groups (n = 5 samples per group). d CXCL-1 secretion from MLE15 cells cultured with 500 pg/mL
TNF-α after transfection with HIF-1α or nontarget siRNA. *p < 0.05 compared with the 21 % O2 group, †p < 0.05
compared with the nontarget group (n = 6 samples per group). NF-κB nuclear factor-κB, HIF-1 hypoxia-inducible
factor 1, VEGFA vascular endothelial growth factor A, GLUT1 glucose transporter-1, K/D knockdown, CXCL-1
chemokine (C-X-C motif) ligand 1
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In this study, we demonstrated increases of proinflammatory cytokines and neutrophil
accumulation in nonventilated atelectatic lungs during ULV. Improvement in alveolar
hypoxia by NTV ventilation with 60 % O2 significantly attenuated these inflammatory
responses; however, NTV ventilation with 0 % O2 did not. These results suggest that al-
veolar hypoxia in atelectasis causes inflammation and may contribute to VALI. More-
over, our in vitro results suggest that hypoxia-induced NF-κB activation is responsible
for increased CXCL-1 secretion from lung epithelial cells in atelectatic lungs, while
HIF-1 negatively regulates CXCL-1 secretion under hypoxic conditions.
The concentrations of inflammatory cytokines in the atelectatic lungs were compar-
able to those in the HTV-ventilated lungs. Moreover, MPO levels were significantly
higher in the atelectatic lungs than in the HTV-ventilated lungs. These data suggest
that the inflammatory responses in the atelectatic lungs were caused by atelectasis rather
than indirectly by contralateral HTV ventilation. There are conflicting reports regarding
the topography of lung inflammation during mechanical ventilation. A previous report
has demonstrated predominant inflammation in the aerated overinflated regions in rats
with surfactant depletion [1]. We used a relatively lower tidal volume and peak Paw com-
pared with that study [1], which used 24 mL/kg tidal ventilation without limitation of
peak Paw. Therefore, the injurious effects of HTV and overinflation may have been min-
imal in the present study. Recently, it has been reported that injurious ventilation with 0
cmH2O PEEP and limitation of peak Paw induces predominant inflammation in the
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mechanical ventilation with moderate HTV ventilation of the nondependent lung, which
is often encountered in clinical settings, may cause predominant inflammation in the
dependent atelectatic lung.
Our ULV protocol did not cause severe lung histological damage, and the alveolar in-
tegrity was maintained. These findings are consistent with our previous report [18]
which demonstrated that HTV ventilation (24 mL/kg) does not cause severe lung injury
without concomitant systemic inflammation induced by hepatic ischemia–reperfusion
in rats. The inflammatory responses that we observed are possible early events of VALI.
These inflammatory responses may not only be reversible [23] but may also lead to se-
vere injury when other multiple injurious events have occurred.
We used 60 % O2 for nonhypoxic condition because 60 % O2 does not show evident
toxicity in healthy animals and is considered to be clinically safe in humans [24]. Mean-
while, it has been reported that exposure of mice with LPS-induced lung injury to 60 %
O2 exaggerates the lung injury [25]. In the present study, bilateral lung ventilation in
healthy rats with 60 % O2 for 8 h did not cause evident inflammation and injury. More-
over, we demonstrated that NTV ventilation with 60 % O2 significantly attenuated the
inflammation in the atelectatic lung; however, anoxic ventilation did not. Although
hyperoxia is harmful to lungs, alveolar hypoxia in the nonaerated, atelectatic lungs also
seems to be a cause of pulmonary inflammation and may contribute to VALI.
The CXCL-1 concentration was not statistically different between the atelectatic lung
and the NTV-ventilated lung with 0 % O2. However, the CXCL-1 concentration tended
to decrease in the NTV0 % group. There are some possible explanations for this appar-
ent decrease. First, the HIF-1 concentration was elevated in the right lungs of the
NTV0 % group compared with those of the ULV group, although there was no differ-
ence in NF-kB DNA-binding activity. The anti-inflammatory effects of HIF-1 may have
contributed to the decreased level of CXCL-1 in the NTV0 % group. Second, the mech-
anical inflation effect of NTV ventilation may have attenuated the CXCL-1 elevation.
Although, the precise mechanisms are unclear, mechanical inflation can attenuate lung
injury induced by ischemia–reperfusion [26, 27]. However, alveolar hypoxia appears to
be the main cause of inflammation in atelectatic lungs because NTV ventilation with
60 % O2 attenuated the inflammation more prominently than those with 0 % O2 did,
The open-chest differential-ventilation rat model offers some advantages. First, we
could investigate the effects of atelectasis in nonventilated lungs without repetitive
shear stress caused by alveolar collapse and reopening [3–5]. Therefore, we could dem-
onstrate that alveolar hypoxia is one of the main causes of lung inflammation in atelec-
tatic lungs. Second, in a previous study of the effects of alveolar hypoxia on lung
inflammation [28], mice exposed to a hypoxic condition developed systemic hypoxemia.
Systemic hypoxemia may have different effects to those of alveolar hypoxia. We could
induce alveolar hypoxia, which is clinically more common in lung injury, and evaluate
its effects without severe systemic hypoxemia.
Our in vitro data suggest that alveolar epithelial cells contribute to hypoxia-induced
inflammation in lungs. In contrast, we did not detect hypoxia-induced inflammatory re-
sponses in alveolar macrophages in vitro. The absence of changes of CCL-2 concentra-
tion in the atelectatic lung is consistent with the in vitro data. Previous studies have
demonstrated that hypoxia-induced CCL-2 release from alveolar macrophages leads to
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lar macrophages occurs early (15 min to 1 h) after exposure to hypoxia. Therefore, it is
possible that the evaluation time points we used in this study did not allow us to detect
increased CCL-2 release from alveolar macrophages.
The NF-κB pathway is required for hypoxia-induced inflammatory gene expression
[31], and inhibition of NF-κB activity attenuates hypobaric hypoxia-induced lung edema
[32]. Our finding that NF-κB activation is responsible for hypoxia-induced increase in
CXCL-1 secretion from lung epithelial cells is consistent with these previous studies
[31, 32]. Regarding HIF-1, HIF-1α is essential for myeloid cell-mediated inflammation
[15], and HIF-1α deletion from the myeloid cell lineage attenuates lipopolysaccharide-
induced sepsis in mice and raises survival rates [17]. HIF1A mRNA expression is in-
creased in shock patients [33], and decreased HIF1A mRNA expression in patients with
sepsis may be associated with depressed immune function [34]. Moreover, drugs inhi-
biting HIF-1 activities attenuate lipopolysaccharide-induced lung injury [35, 36]. How-
ever, some reports suggest that HIF-1 has anti-inflammatory effects. Targeted deletion
of HIF-1α in T lymphocytes in mice with bacterial sepsis leads to higher levels of proin-
flammatory cytokines and stronger antibacterial capacities [37]. HIF-1 activation in
lung epithelial cells protects against VALI through optimization of carbohydrate metab-
olism [38]. Our finding that HIF-1 knockdown augments hypoxia-induced increase in
CXCL-1 secretion from lung epithelial cells suggests that HIF-1 activation in atelectatic
lungs may be a protective response to hypoxia and prevents lung inflammation and in-
jury. Further investigations on the roles of HIF-1 in lung injury are warranted.
Alveolar hypoxia in the atelectatic lung may be a novel therapeutic target for VALI.
Our results support the rationale for open lung approaches, including application of
higher PEEP and lung recruitment maneuvers. The clinical benefits of the open lung
approach [39] may contribute to the improvement of alveolar hypoxia. On the other
hand, the increase of the inspired O2 fraction may also increase alveolar oxygen tension
even when atelectasis exists [40]. Although it is possible that higher oxygen concentra-
tion shows toxic effects, increasing inspired O2 fraction may be able to attenuate
hypoxia-induced inflammatory responses in the atelectatic lung region. Clinical trials to
investigate optimal strategies to adjust the inspired O2 fraction are thus warranted.
This study has several limitations. First, the differential-ventilation model may not ac-
curately reflect uneven mechanical ventilation in clinical settings, although it has some
advantages as described previously. Second, although the systemic circulation was not
severely impaired by ULV, we could not control pulmonary circulation during ULV.
Pulmonary hypertension in response to alveolar hypoxia in atelectatic lungs may have
contributed to lung injury [40, 41]. However, our in vitro observation that hypoxia sig-
nificantly increases CXCL-1 secretion from lung epithelial cells strongly suggests that
alveolar hypoxia is one of the main causes of inflammatory responses in atelectatic
lungs. Third, the follow-up period was up to 8 h, and we did not evaluate any func-
tional outcomes, such as mortality. Further investigations are needed to evaluate long-
term effects of alveolar hypoxia in the atelectatic lungs on VALI. Fourth, we evaluated
the contributions of NF-κB and HIF-1 to hypoxia-induced lung inflammation only in a
lung epithelial cell line and by considering a single inflammatory mediator in vitro. Al-
though, the critical role of CXCL-1 for the pathogenesis of VALI has been reported
[42], further studies using animals and another cell types are needed.
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Atelectasis causes alveolar hypoxia-induced inflammatory responses including NF-κB-
dependent CXCL-1 secretion from lung epithelial cells. HIF-1 activation in lung epithelial
cells is an anti-inflammatory response to alveolar hypoxia in atelectatic lungs. Modulation
of HIF-1α and NF-κB in lung epithelial cells may present therapeutic approaches for VALI.
Key messages
 Atelectasis causes alveolar hypoxia-induced inflammatory responses including NF-
κB-dependent CXCL-1 secretion from lung epithelial cells.
 HIF-1 activation in lung epithelial cells is an anti-inflammatory response to alveolar
hypoxia in atelectatic lungs.
Abbreviations
ACTB: β-actin; ANOVA: analysis of variance; BLV: bilateral lung ventilation; CCL-2: chemokine (C-C motif) ligand 2;
CXCL-1: chemokine (C-X-C motif) ligand 1; ELISA: enzyme-linked immunosorbent assay; FBS: fetal bovine serum;
GLUT1: glucose transporter-1; HIF-1: hypoxia-inducible factor 1; HTV: high tidal volume; IκB: inhibitors of κB;
IL: interleukin; MAP: mean arterial pressure; MPO: myeloperoxidase; NF-κB: nuclear factor-κB; NTV: normal tidal volume;
PaCO2: arterial partial pressure of carbon dioxide; PaO2: arterial partial pressure of oxygen; Paw: airway pressure;
PEEP: positive end-expiratory pressure; PHD: prolyl hydroxylase; qPCR: quantitative polymerase chain reaction;
siRNA: small interfering RNA; TNF-α: tumor necrosis factor α; ULV: unilateral lung ventilation; VALI: ventilator-associated
lung injury; VEGFA: vascular endothelial growth factor A.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KT conceived of and designed the study, performed the animal and biochemical experiments, analyzed the data, and
wrote and edited the manuscript. YN participated in the study design and performed the animal experiments. TY
performed the histological analysis. TM participated in the study design and statistical analysis and edited the
manuscript. YB and SO participated in the study design. TG participated in the study design and edited the
manuscript. KK conceived of the study, participated in its design and coordination, and edited the manuscript. All
authors read and approved the final manuscript.
Acknowledgements
The authors would like to thank Yuki Yuba and Akiko Adachi (Department of Anesthesiology and Critical Care
Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan) for technical assistance.
This study was supported in part by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research
no. 23592303 (to KK).
Author details
1Department of Anesthesiology and Critical Care Medicine, Yokohama City University Graduate School of Medicine,
3-9, Fukuura, Kanazawa-ku, Yokohama-city, Kanagawa 236-0004, Japan. 2Department of Diagnostic Pathology, Chiba
University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba-city, Chiba 260-8670, Japan. 3Department of
Anesthesiology, Kanagawa Children’s Medical Center, 2-138-4, Mutsukawa, Minami-ku, Yokohama-city, Kanagawa
232-8555, Japan. 4Operation Department, Yokohama City University Medical Center, 4-57, Urafune, Minami-ku,
Yokohama-city, Kanagawa 232-0024, Japan. 5Department of Palliative Care Medicine, Kanagawa Cancer Center, 2-3-2,
Nakao, Asahi-ku, Yokohama-city, Kanagawa 241-8515, Japan.
Received: 1 January 2015 Accepted: 9 June 2015
References
1. Tsuchida S, Engelberts D, Peltekova V et al (2006) Atelectasis causes alveolar injury in nonatelectatic lung regions.
Am J Respir Crit Care Med 174:279–289. doi:10.1164/rccm.200506-1006OC
2. Retamal J, Bergamini B, Carvalho AR et al (2014) Non-lobar atelectasis generates inflammation and structural alveolar
injury in the surrounding healthy tissue during mechanical ventilation. Crit Care 18:505. doi:10.1186/s13054-014-0505-1
3. Muscedere JG, Mullen JB, Gan K, Slutsky AS (1994) Tidal ventilation at low airway pressures can augment lung
injury. Am J Respir Crit Care Med 149:1327–1334. doi:10.1164/ajrccm.149.5.8173774
4. Taskar V, John J, Evander E et al (1997) Surfactant dysfunction makes lungs vulnerable to repetitive collapse and
reexpansion. Am J Respir Crit Care Med 155:313–320. doi:10.1164/ajrccm.155.1.9001330
5. Halter JM, Steinberg JM, Gatto LA et al (2007) Effect of positive end-expiratory pressure and tidal volume on lung
injury induced by alveolar instability. Crit Care 11:R20. doi:10.1186/cc5695
6. Morrell NW, Nijran KS, Biggs T, Seed WA (1995) Magnitude and time course of acute hypoxic pulmonary
vasoconstriction in man. Respir Physiol 100:271–281. doi:10.1016/0034-5687(95)00002-U
Tojo et al. Intensive Care Medicine Experimental  (2015) 3:18 Page 16 of 177. Frohlich S, Boylan J, McLoughlin P (2013) Hypoxia-induced inflammation in the lung: a potential therapeutic target
in acute lung injury? Am J Respir Cell Mol Biol 48:271–279. doi:10.1165/rcmb.2012-0137TR
8. Taylor CT (2008) Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation.
J Physiol Lond 586:4055–4059. doi:10.1113/jphysiol.2008.157669
9. Eltzschig HK, Carmeliet P (2011) Hypoxia and inflammation. N Engl J Med 364:656–665. doi:10.1056/
NEJMra0910283
10. Tak PP, Firestein GS (2001) NF-κB: a key role in inflammatory diseases. J Clin Invest 107:7–11. doi:10.1172/JCI11830
11. Cummins EP, Berra E, Comerford KM et al (2006) Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta,
giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A 103:18154–18159. doi:10.1073/
pnas.0602235103
12. Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148:399–408. doi:10.1016/
j.cell.2012.01.021
13. Sitkovsky MV, Lukashev D, Apasov S et al (2004) Physiological control of immune response and inflammatory
tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 22:657–682.
doi:10.1146/annurev.immunol.22.012703.104731
14. Walmsley SR (2005) Hypoxia-induced neutrophil survival is mediated by HIF-1-dependent NF-B activity. J Exp Med
201:105–115. doi:10.1084/jem.20040624
15. Cramer T, Yamanishi Y, Clausen BE, et al. (2003) HIF-1α is essential for myeloid cell-mediated inflammation. Cell
112:645–657. doi: 10.1016/S0092-8674(03)00154-5.
16. Peyssonnaux C, Datta V, Cramer T et al (2005) HIF-1alpha expression regulates the bactericidal capacity of phagocytes.
J Clin Invest 115:1806–1815. doi:10.1172/JCI23865
17. Peyssonnaux C, Cejudo-Martin P, Doedens A et al (2007) Cutting edge: essential role of hypoxia inducible factor-1α in
development of lipopolysaccharide-induced sepsis. J Immunol 178:7516–7519
18. Ota S, Nakamura K, Yazawa T et al (2007) High tidal volume ventilation induces lung injury after hepatic ischemia-
reperfusion. Am J Physiol Lung Cell Mol Physiol 292:L625–L631. doi:10.1152/ajplung.00151.2006
19. Matute-Bello G, Downey G, Moore BB et al (2011) An official American Thoracic Society workshop report: features
and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 44:725–738.
doi:10.1165/rcmb.2009-0210ST
20. Imai Y, Kawano T, Iwamoto S et al (1999) Intratracheal anti-tumor necrosis factor-alpha antibody attenuates
ventilator-induced lung injury in rabbits. J Appl Physiol 87:510–515
21. Bertok S, Wilson MR, Morley PJ et al (2012) Selective inhibition of intra-alveolar p55 TNF receptor attenuates
ventilator-induced lung injury. Thorax 67:244–251. doi:10.1136/thoraxjnl-2011-200590
22. de Prost N, Costa EL, Wellman T et al (2013) Effects of ventilation strategy on distribution of lung inflammatory
cell activity. Crit Care 17:R175. doi:10.1186/cc12854
23. Vaneker M, Halbertsma FJ, van Egmond J et al (2007) Mechanical ventilation in healthy mice induces reversible
pulmonary and systemic cytokine elevation with preserved alveolar integrity: an in vivo model using clinical
relevant ventilation settings. Anesthesiology 107:419–426. doi:10.1097/01.anes.0000278908.22686.01
24. Kallet RH, Matthay MA (2012) Hyperoxic acute lung injury. Respir Care 58:123–141. doi:10.4187/respcare.01963
25. Thiel M, Chouker A, Ohta A et al (2005) Oxygenation inhibits the physiological tissue-protecting mechanism and
thereby exacerbates acute inflammatory lung injury. PLoS Biol 3:e174. doi:10.1371/journal.pbio.0030174
26. Srinivasan HB, Vogel SM, Vidyasagar D, Malik AB (2000) Protective effect of lung inflation in reperfusion-induced
lung microvascular injury. Am J Physiol Heart Circ Physiol 278:H951–H957
27. Kao SJ, Wang D, Yeh DY-W et al (2004) Static inflation attenuates ischemia/reperfusion injury in an isolated rat
lung in situ. Chest 126:552–558. doi:10.1378/chest.126.2.552
28. Madjdpour C, Jewell UR, Kneller S et al (2003) Decreased alveolar oxygen induces lung inflammation. Am J Physiol
Lung Cell Mol Physiol 284:L360–L367. doi:10.1152/ajplung.00158.2002
29. Chao J, Wood JG, Blanco VG, Gonzalez NC (2009) The systemic inflammation of alveolar hypoxia is initiated by
alveolar macrophage-borne mediator(s). Am J Respir Cell Mol Biol 41:573–582. doi:10.1165/rcmb.2008-0417OC
30. Chao J, Donham P, van Rooijen N et al (2011) Monocyte chemoattractant protein-1 released from alveolar
macrophages mediates the systemic inflammation of acute alveolar hypoxia. Am J Respir Cell Mol Biol
45:53–61. doi:10.1165/rcmb.2010-0264OC
31. Fitzpatrick SF, Tambuwala MM, Bruning U et al (2011) An intact canonical NF-κB pathway is required for inflammatory
gene expression in response to hypoxia. J Immunol 186:1091–1096. doi:10.4049/jimmunol.1002256
32. Sarada S, Himadri P, Mishra C et al (2008) Role of oxidative stress and NFkB in hypoxia-induced pulmonary edema.
Exp Biol Med (Maywood) 233:1088–1098. doi:10.3181/0712-RM-337
33. Textoris J, Beaufils N, Quintana G et al (2012) Hypoxia-inducible factor (HIF1α) gene expression in human shock
states. Crit Care 16:R120. doi:10.1186/cc11414
34. Schäfer ST, Frede S, Winning S et al (2013) Hypoxia-inducible factor and target gene expression are decreased in
patients with sepsis: prospective observational clinical and cellular studies. Anesthesiology 118:1426–1436.
doi:10.1097/ALN.0b013e31828baa67
35. Xu M, Cao F, Liu L et al (2011) Tanshinone IIA-induced attenuation of lung injury in endotoxemic mice is associated
with reduction of hypoxia-inducible factor 1α expression. Am J Respir Cell Mol Biol 45:1028–1035. doi:10.1165/
rcmb.2011-0113OC
36. Yeh CH, Cho W, So EC et al (2011) Propofol inhibits lipopolysaccharide-induced lung epithelial cell injury by reducing
hypoxia-inducible factor-1 expression. Br J Anaesth 106:590–599. doi:10.1093/bja/aer005
37. Thiel M, Caldwell CC, Kreth S et al (2007) Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition
in hypoxic inflamed tissues and improves septic mice survival. PLoS One 2:e853. doi:10.1371/journal.pone.0000853
38. Eckle T, Brodsky K, Bonney M et al (2013) HIF1A reduces acute lung injury by optimizing carbohydrate metabolism
in the alveolar epithelium. PLoS Biol 11:e1001665. doi:10.1371/journal.pbio.1001665.s009
Tojo et al. Intensive Care Medicine Experimental  (2015) 3:18 Page 17 of 1739. Briel M, Meade M, Mercat A et al (2010) Higher vs lower positive end-expiratory pressure in patients with acute
lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 303:865–873.
doi:10.1001/jama.2010.218
40. Duggan M, McNamara PJ, Engelberts D et al (2005) Oxygen attenuates atelectasis-induced injury in the in vivo rat
lung. Anesthesiology 103:522–531
41. Duggan M, McCaul CL, McNamara PJ et al (2003) Atelectasis causes vascular leak and lethal right ventricular
failure in uninjured rat lungs. Am J Respir Crit Care Med 167:1633–1640. doi:10.1164/rccm.200210-1215OC
42. Belperio JA, Keane MP, Burdick MD et al (2002) Critical role for CXCR2 and CXCR2 ligands during the pathogenesis
of ventilator-induced lung injury. J Clin Invest 110:1703–1716. doi:10.1172/JCI15849Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
